Cinctive Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.46M | Sell |
22,868
-1,994
| -8% | -$650K | 0.39% | 76 |
|
|
2025
Q1 | $6.71M | Buy |
24,862
+6,622
| +36% | +$1.79M | 0.51% | 57 |
|
|
2024
Q4 | $4.29M | Buy |
+18,240
| New | +$4.29M | 0.22% | 143 |
|
|
2024
Q3 | – | Sell |
-6,781
| Closed | -$1.65M | – | 361 |
|
|
2024
Q2 | $1.65M | Sell |
6,781
-203
| -3% | -$49.3K | 0.08% | 247 |
|
|
2024
Q1 | $1.04M | Buy |
+6,984
| New | +$1.04M | 0.05% | 268 |
|
|
2022
Q1 | – | Sell |
-6,990
| Closed | -$1.19M | – | 439 |
|
|
2021
Q4 | $1.19M | Buy |
+6,990
| New | +$1.19M | 0.05% | 356 |
|
|
2021
Q1 | – | Sell |
-27,721
| Closed | -$3.6M | – | 399 |
|
|
2020
Q4 | $3.6M | Buy |
+27,721
| New | +$3.6M | 0.29% | 140 |
|